In a filing, Regeneron Pharmaceuticals, Inc revealed its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.84 million on Nov 01 ’24. In the deal valued at $844.61 per share,1,000 shares were sold. As a result of this transaction, McCourt Marion now holds 12,931 shares worth roughly $9.29 million.
Then, MARION E MCCOURT bought 1,000 shares, generating $844,610 in total proceeds.
Before that, RYAN ARTHUR F sold 100 shares. Regeneron Pharmaceuticals, Inc shares valued at $104,878 were divested by the Director at a price of $1048.78 per share. As a result of the transaction, RYAN ARTHUR F now holds 17,582 shares, worth roughly $12.63 million.
A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. Citigroup began covering REGN with “Neutral” recommendation on November 14, 2024. Leerink Partners revised its rating on September 24, 2024. It rated REGN as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of REGN
On Friday, Regeneron Pharmaceuticals, Inc [NASDAQ:REGN] saw its stock jump 0.41% to $718.15. Over the last five days, the stock has gained 0.21%. Regeneron Pharmaceuticals, Inc shares have risen nearly 0.82% since the year began. Nevertheless, the stocks have fallen -21.73% over the past one year. While a 52-week high of $1211.20 was reached on 01/02/25, a 52-week low of $693.00 was recorded on 01/02/25. SMA at 50 days reached $780.85, while 200 days put it at $970.97.
Levels Of Support And Resistance For REGN Stock
The 24-hour chart illustrates a support level at 714.61, which if violated will result in even more drops to 711.06. On the upside, there is a resistance level at 721.85. A further resistance level may holdings at 725.54. The Relative Strength Index (RSI) on the 14-day chart is 39.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.63%. Stochastics %K at 32.04% indicates the stock is a holding.
How much short interest is there in Regeneron Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Regeneron Pharmaceuticals, Inc stocks on 2024-12-13, growing by 93887.0 shares to a total of 1.88 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 1.79 million shares. There was a rise of 4.99%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 12, 2024 when Bernstein began covering the stock and recommended ‘”an Outperform”‘ rating along with a $1125 price target.
